Eton Pharmaceuticals Inc
NASDAQ:ETON 4:00:00 PM EDT
Market Cap (Intraday) | 95.06M |
Current PE | N/A |
Forward PE | 14.42 |
2yr Forward PE | N/A |
10-Day MA | $3.85 |
50-Day MA | $4.32 |
200-Day MA | $4.05 |
Eton Pharmaceuticals Inc Stock, NASDAQ:ETON
21925 West Field Parkway, Suite 235, Deer Park, Illinois 60010-7278
United States of America
Phone: +1.847.787.7361
Number of Employees: 30
Description
Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.